Peritoneal Neoplasms: all 366 studies
Page 1 of 4. Open to participants first (56), then studies with results posted, then the rest; newest registration first within each.
- Paricalcitol Versus Pirfenidone for Improving Surgical Resectability in Patients With Peritoneal CancerNot yet recruitingNCT07856914Phase 2
- Remimazolam Versus Propofol for Early Recovery After Cytoreductive SurgeryNot yet recruitingNCT07785557Not applicable
- The Appendix Cancer PMP Research Foundation Natural History Study/Patient RegistryRecruitingNCT07769346
- TLR9 Immunotherapy for Peritoneal CarcinomatosisRecruitingNCT07658196Phase 1
- MRI-Guided Adaptive Radiotherapy for Limited Peritoneal Metastases (MARACAS Trial).Not yet recruitingNCT07593261Phase 2
- Intensification Treatment of Ovarian Cancer by PIPACRecruitingNCT07514494Phase 2
- Enhanced Recovery After Surgery (ERAS) in Patients With Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)RecruitingNCT07493876Not applicable
- To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.RecruitingNCT07493421Not applicable
- Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid TumorsRecruitingNCT07487168Phase 1
- Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.RecruitingNCT07451483
- Heated Versus Aerosol-based Laparoscopic Chemotherapy for Cancer That Has Spread to the Peritoneum (Abdominal Lining)RecruitingNCT07282834Phase 2
- Tolerance, Safety, Efficacy, and Pharmacokinetics of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel for Platinum-resistant Recurrent Ovarian CancerNot yet recruitingNCT07273396Phase 1/2
- Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)RecruitingNCT07219238Phase 2/3
- A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian CancerRecruitingNCT07213804Phase 3
- Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal CarcinomatosisRecruitingNCT07030283Phase 1
- Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal CavityRecruitingNCT07001748Phase 2/3
- Blood Clearance Kinetics of the Nucleosome and CTCF in Peritoneal Metastasis Colorectal Cancer.RecruitingNCT06929013Not applicable
- Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological CancersRecruitingNCT06906341Phase 2
- Prophylactic PIPAC in Patients With High-risk Colorectal CancerNot yet recruitingNCT06839092Phase 3
- A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer or Malignant Peritoneal MesotheliomaRecruitingNCT06623396Phase 1
- PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal CarcinomatosisRecruitingNCT06511037Early Phase 1
- A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking SurgeryRecruitingNCT06504147Phase 2
- International Registration of Isolated STIC: to Report and Investigate the Risk of Serous Peritoneal CarcinomatosisNot yet recruitingNCT06393543
- Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Surgery With Hyperthermic Intraperitoneal ChemotherapyRecruitingNCT06351475Not applicable
- SUROVA - Surgery in Ovarian Cancer, Comparing Primary and Interval Cytoreductive SurgeryRecruitingNCT06223763
- Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal CarcinomatosisRecruitingNCT06061874Not applicable
- Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)RecruitingNCT05913674Phase 2
- Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal CarcinomatosisRecruitingNCT05844865Not applicable
- A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian CancerRecruitingNCT05801783Early Phase 1
- Huaier Granule in Patients With Stage I Primary Ovarian Fallopian Tube Cancer After Peritoneal CancerNot yet recruitingNCT05792254Not applicable
- Serplulimab Combined With FOLFIRI and Bevacizumab in the Treatment of Colon Cancer Peritoneal MetastasesRecruitingNCT05742425Phase 2
- Response Prediction of Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal CancerRecruitingNCT05652348
- Oregovomab and PLD in PARP Inhibitor Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients Not Candidate for Platinum RetreatmentRecruitingNCT05407584Phase 2
- Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) and Electrostatic PIPAC (ePIPAC) With Paclitaxel In Patients With Peritoneal CarcinomatosisRecruitingNCT05395910Phase 1
- Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine Chemotherapy for Pancreatic Cancer Peritoneal MetastasesRecruitingNCT05371223Phase 2
- Preoperative Systemic Therapy for Colorectal Cancer Peritoneal MetastasesNot yet recruitingNCT05353582Phase 2
- Clinical Trial on HIPEC with Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC)RecruitingNCT05250648Phase 4
- Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal HistologiesRecruitingNCT04847063Phase 1
- Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel ObstructionRecruitingNCT04840264Phase 2
- Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian CancerRecruitingNCT04811703Phase 1
- Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPECRecruitingNCT04779554Phase 2
- PITCHER (Peritoneal Carcinomatosis Heterogeneity)RecruitingNCT04714957
- Oncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With T3-4 Gastric Cancer Cyt-RecruitingNCT04595929Not applicable
- Complete Cytoreduction Followed by IP and Systemic Chemotherapies for Gastric Cancer With Peritoneal CarcinomatosisRecruitingNCT04547725Not applicable
- Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal CarcinomatosisRecruitingNCT04370925Phase 3
- PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric CancerRecruitingNCT04329494Phase 1
- MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)RecruitingNCT04111978Phase 3
- Longitudinal Study of CRS/HIPEC for Peritoneal CarcinomatosesRecruitingNCT04108936
- Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric CancerRecruitingNCT04107077Phase 2
- Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal CarcinosisRecruitingNCT04024917Not applicable
- Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal CancersRecruitingNCT03976999Not applicable
- Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer PatientsRecruitingNCT03280511Phase 2
- Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal CarcinomatosisRecruitingNCT03073694Phase 2
- Peritoneal Surface Malignancies - Characterization, Models and Treatment StrategiesRecruitingNCT02073500
- Integrated Cancer Repository for Cancer ResearchRecruitingNCT02012699
- Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was PerformedRecruitingNCT01617382
- SurgiPerito Trial: High-Purity Type-I Collagen for Peritoneal Reconstruction After Cytoreductive SurgeryCompletedNCT07241091Not applicableResults posted
- Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube CancerActive, not recruitingNCT05257408Phase 3Results posted
- Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal CarcinomatosisCompletedNCT05185947Phase 2Results posted
- A Study to Evaluate ONM100, an Intraoperative Fluor Imaging Agent for the Detection of Peri MetsCompletedNCT04950166Phase 2Results posted
- Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal CarcinomatosisTerminatedNCT04034251Phase 2Results posted
- Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)CompletedNCT03740165Phase 3Results posted
- Talimogene Laherparepvec for the Treatment of Peritoneal Surface MalignanciesCompletedNCT03663712Phase 1Results posted
- A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT03635489Phase 3Results posted
- Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of MalignancyCompletedNCT03593681Results posted
- PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian CancerCompletedNCT03304210Phase 1Results posted
- A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT03038100Phase 3Results posted
- IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing SurgeryTerminatedNCT03029611Phase 2Results posted
- Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.CompletedNCT02903771Phase 1Results posted
- Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal CancerCompletedNCT02891447Phase 2Results posted
- Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal CancerCompletedNCT02865811Phase 2Results posted
- ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PatientsCompletedNCT02855944Phase 3Results posted
- Olvi-Vec Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian CancerCompletedNCT02759588Phase 1/2Results posted
- Role of Intraperitoneal Intraoperative Chemotherapy With Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis From Ovarian Cancer. Hyperthermia Versus NormothermiaCompletedNCT02739698Phase 2Results posted
- Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT02713386Phase 1/2Results posted
- Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCTCompletedNCT02638051Phase 2Results posted
- Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT02606305Phase 1/2Results posted
- Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian or Peritoneal CancerTerminatedNCT02575807Phase 1/2Results posted
- Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients With Abdominal Cancer Undergoing SurgeryCompletedNCT02356471Not applicableResults posted
- Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal CancerCompletedNCT02311907Phase 3Results posted
- Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT02272790Phase 2Results posted
- Adjuvant HIPEC in High Risk Colon CancerCompletedNCT02231086Phase 3Results posted
- αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface MalignanciesCompletedNCT02151448Phase 1/2Results posted
- HIPEC for Peritoneal CarcinomatosisCompletedNCT02040142Phase 2Results posted
- A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)CompletedNCT01891344Phase 2Results posted
- Tivozanib in Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal CancerCompletedNCT01853644Phase 2Results posted
- A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT01846611Phase 3Results posted
- Surgery and Heated Chemotherapy for Adrenocortical CarcinomaCompletedNCT01833832Phase 2Results posted
- Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal CancerTerminatedNCT01744821Not applicableResults posted
- Randomized Controlled Trial to Prevent Peritoneal Seeding in Gastric CancerTerminatedNCT01683864Phase 2/3Results posted
- Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal CancerTerminatedNCT01681368Phase 2Results posted
- VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal CancerCompletedNCT01666444Phase 2Results posted
- Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the AppendixCompletedNCT01580410Phase 2Results posted
- Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in Gynecologic PatientsCompletedNCT01579812Phase 2Results posted
- BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal CancerCompletedNCT01314105Phase 1Results posted
- Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal CancerCompletedNCT01313078Phase 2Results posted
- A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal CancerTerminatedNCT01312389Phase 1/2Results posted
- Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian CancerTerminatedNCT01275664Not applicableResults posted
- Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal CancerCompletedNCT01248962Phase 2Results posted
- Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal CancerCompletedNCT01188876Phase 1/2Results posted